Peginterferon alfa-2b biosimilar (Virchow Biotech)

聚乙二醇干扰素α-2b生物类似药 (Virchow Biotech)

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePeginterferon alfa-2b biosimilar (Virchow Biotech)
Drug Alias NamePEG-Inferon (Virchow Biotech)聚乙二醇干扰素α-2b生物仿制药 (Virchow Biotech)VIPEG
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionImmunostimulantsInnate antiviral immune response inducersInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsHepatitis, ChronicHepatitis CHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesVirchow Group
China Registration ClassN/A

Develop Information

Active CompaniesVirchow Group
Inactive CompaniesN/A
Active IndicationsHepatitis, ChronicHepatitis CHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeL03AB10
Related LinksN/A